Skip to content
OpenCapital
Get started

Impact BioMedical IBO Q3 2025 earnings

Reported November 7, 2025 · Before market open

Revenue$18.0K
EPS-$0.12

Next report

Date not yet announced

Versus estimates

Revenue

Q1 2026$7.0KQ4 2025$7.0K
Q3 2025$18.0K
Q2 2025$5.1K

Diluted EPS

Q1 2026-$0.02Q4 2025-$0.42
Q3 2025-$0.12
Q2 2025-$1.18Q1 2025-$0.11Q4 2024-$0.42

Ask the moment Impact BioMedical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Impact BioMedical report Q3 2025 earnings?
Impact BioMedical (IBO) reported Q3 2025 earnings on November 7, 2025 before market open.
What were Impact BioMedical's Q3 2025 revenue and EPS?
Impact BioMedical reported revenue of $18.0K and eps of $-0.12 for Q3 2025.
How did Impact BioMedical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 500.0% from $-0.02.
Where can I find Impact BioMedical's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021066) and the 10-Q periodic report (0001493152-25-021286) directly on SEC EDGAR. The filing index links above go to sec.gov.